Biblio

Export 128 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
D. R. Roalf, Quarmley, M., Mechanic-Hamilton, D., Wolk, D. A., Arnold, S. E., and Moberg, P. J., Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment., J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
D. Rizzuto, Feldman, A. L., Karlsson, I. K., Aslan, A. K. Dahl, Gatz, M., and Pedersen, N. L., Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study., J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.
A. Rivero-Santana, Ferreira, D., Perestelo-Pérez, L., Westman, E., Wahlund, L. - O., Sarría, A., and Serrano-Aguilar, P., Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors., J Alzheimers Dis, vol. 55, no. 2, pp. 625-644, 2017.
A. Ritter, Hawley, N., Banks, S. J., and Miller, J. B., The Association between Montreal Cognitive Assessment Memory Scores and Hippocampal Volume in a Neurodegenerative Disease Sample., J Alzheimers Dis, vol. 58, no. 3, pp. 695-699, 2017.
K. Ritter, Lange, C., Weygandt, M., Mäurer, A., Roberts, A., Estrella, M., Suppa, P., Spies, L., Prasad, V., Steffen, I., Apostolova, I., Bittner, D., Gövercin, M., Brenner, W., Mende, C., Peters, O., Seybold, J., Fiebach, J. B., Steinhagen-Thiessen, E., Hampel, H., Haynes, J. - D., and Buchert, R., Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients., J Alzheimers Dis, vol. 54, no. 4, pp. 1319-1331, 2016.
K. Ritchie, Carrière, I., Howett, D., Su, L., Hornberger, M., O'Brien, J. T., Ritchie, C. W., and Chan, D., Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study., J Alzheimers Dis, vol. 65, no. 3, pp. 885-896, 2018.
C. W. Ritchie, Khandker, R. K., Pike, J., Black, C. M., Jones, E., and Ambegaonkar, B. M., Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 3, pp. 899-910, 2018.
C. W. Ritchie, Black, C. M., Khandker, R. K., Wood, R., Jones, E., Hu, X., and Ambegaonkar, B. M., Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries., J Alzheimers Dis, vol. 62, no. 1, pp. 457-466, 2018.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics., J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
J. M. Riphagen, van Egroo, M., and Jacobs, H. I. L., Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline., J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
E. L. Richard, Kritz-Silverstein, D., Laughlin, G. A., Fung, T. T., Barrett-Connor, E., and McEvoy, L. K., Alcohol Intake and Cognitively Healthy Longevity in Community-Dwelling Adults: The Rancho Bernardo Study., J Alzheimers Dis, vol. 59, no. 3, pp. 803-814, 2017.
J. Riancho, Pozueta, A., Santos, M., Lage, C., Carril, J. M., Banzo, I., Martínez-Rodriguez, I., Gorno-Tempini, M., and Sánchez-Juan, P., Logopenic Aphasia due to a Strategic Stroke: New Evidence from a Single Case., J Alzheimers Dis, vol. 57, no. 3, pp. 717-721, 2017.
J. Riancho, Vázquez-Higuera, J. Luis, Pozueta, A., Lage, C., Kazimierczak, M., Bravo, M., Calero, M., Gonalezález, A., Rodríguez, E., Lleo, A., and Sánchez-Juan, P., MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples., J Alzheimers Dis, vol. 57, no. 2, pp. 483-491, 2017.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
E. M. Rhea, Humann, S. R., Nirkhe, S., Farr, S. A., Morley, J. E., and Banks, W. A., Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition., J Alzheimers Dis, vol. 57, no. 1, pp. 241-252, 2017.
A. Reuben, Childhood Lead Exposure and Adult Neurodegenerative Disease., J Alzheimers Dis, vol. 64, no. 1, pp. 17-42, 2018.
Ede Paula F. Resende, Ketelle, R., Karydas, A., Allen, I., Grinberg, L. T., Spina, S., Seeley, W. W., Perry, D. C., Miller, B., and Naasan, G., Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases., J Alzheimers Dis, vol. 86, no. 3, pp. 1073-1080, 2022.
R. Resende, Ferreira-Marques, M., Moreira, P., Coimbra, J. R. M., Baptista, S. J., Isidoro, C., Salvador, J. A. R., Dinis, T. C. P., Pereira, C. F., and Santos, A. E., New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models., J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
D. Renard, Tatu, L., Collombier, L., Wacongne, A., Ayrignac, X., Charif, M., Boukriche, Y., Chiper, L., Fourcade, G., Azakri, S., Gaillard, N., Mercier, E., Lehmann, S., and Thouvenot, E., Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features., J Alzheimers Dis, vol. 64, no. 4, pp. 1113-1121, 2018.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
D. Renard, Gabelle, A., Hirtz, C., Demattei, C., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis., J Alzheimers Dis, vol. 54, no. 4, pp. 1291-1295, 2016.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
D. Ren, Lopez, O. L., Lingler, J. H., and Conley, Y., Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans., J Alzheimers Dis, vol. 81, no. 3, pp. 943-948, 2021.
P. Ren, Lo, R. Y., Chapman, B. P., Mapstone, M., Porsteinsson, A., and Lin, F., Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment., J Alzheimers Dis, vol. 54, no. 1, pp. 69-78, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease., J Alzheimers Dis, 2015.

Pages